Electron-capture GLC assay of dichlorphenamide

Area of Science:

• Analytical Chemistry
• Pharmacology
• Biochemistry

Background:

• Carbonic anhydrase inhibitors are crucial in treating various medical conditions.
• Accurate quantification of drugs like dichlorphenamide in biological matrices is essential for pharmacokinetic and pharmacodynamic studies.
• Existing analytical methods may lack the required sensitivity or specificity for complex biological samples.

Purpose of the Study:

• To develop and validate a sensitive analytical method for determining dichlorphenamide concentrations.
• To quantify dichlorphenamide in rabbit serum and aqueous humor following administration.
• To establish a reliable assay for carbonic anhydrase inhibitor analysis in biological fluids.

Main Methods:

• Gas-liquid chromatography (GLC) coupled with electron-capture detection (ECD) was employed.
• Dichlorphenamide and an internal standard (monochlorphenamide) were extracted from serum and aqueous humor.
• A nucleophilic alkylation method was used to convert the analytes into their tetramethyl derivatives for enhanced detection.

Main Results:

• The developed GLC-ECD method demonstrated high sensitivity, detecting as little as 10 ng of dichlorphenamide.
• The assay was successfully applied to quantify dichlorphenamide in 0.5 ml of rabbit serum and 0.25 ml of aqueous humor.
• Dichlorphenamide concentrations in both serum and aqueous humor of treated rabbits were successfully determined.

Conclusions:

• GLC with electron-capture detection provides a sensitive and reliable method for assaying dichlorphenamide in biological samples.
• The method is suitable for pharmacokinetic studies and therapeutic drug monitoring of dichlorphenamide.
• This assay facilitates the understanding of dichlorphenamide distribution and metabolism in vivo.